已收盤 02-06 16:00:00 美东时间
-4.130
-1.14%
Stryker Group President James Andrew Pierce Reports Disposal of Common Shares James Andrew Pierce, Group President of Stryker Corporation, has reported a disposal of common shares of Stryker Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was created
02-04 05:09
今日重点评级关注:HC Wainwright & Co.:维持Praxis Precision Medicine"买入"评级,目标价从340美元升至1245美元;HC Wainwright & Co.:维持Perspective Therapeutics"买入"评级,目标价从10美元升至12美元
02-02 14:15
BUZZ-U.S. STOCKS ON THE MOVE-Church & Dwight, Tesla, Oppenheimer Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks fell on Friday after President Donald Trump nominated for
01-31 02:38
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-30 21:17
BUZZ-Stryker rises after raising annual profit forecast ** Shares of medical device maker Stryker SYK.N rise 1.3% to $359 premarket ** The company said late on Thursday that it expects adjusted full-year earnings per share of $14.90 to $15.10, compared with its previous view of $13.50 to $13.60 ** S
01-30 20:57
BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $410 to $412.
01-30 18:42
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Stryker 2025年第四季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 第四季度有机销售增长11%,全年有机销售增长10.3% - 2025年总净销售额超过250亿美元 - 美国有机销售增长全年达11.2%,国际市场有机销售增长7.5% **盈利能力:** - 第四季度调整后每股收益4.47美元,同比增长11.5% - 全年调整后每股收益13.63美元,同比增长11.8% - 第四季度调整后毛利率65.2%,较2024年第四季度下降10个基点 - 第四季度调整后营业利润率30.2%,同比提升100个基
01-30 12:18
Stryker raises annual profit forecast on strong sales for medical devices By Bageshri Banerjee Jan 22 - Medical e quipment maker Stryker raised its full-year profit forecast on Thursday, banking on strong sales of its implants and other medical devices. Shares of the company rose as much as 3% in ex
01-30 07:48
Stryker shares are trading higher after the company reported better-than-expect...
01-30 05:26
Stryker Q4 net sales rise 11.4%, beat estimates Overview Medical technologies firm's Q4 net sales rose 11.4%, beating analyst expectations Adjusted EPS for Q4 increased 11.5%, beating analyst expectations Company expects 2026 organic net sales growth of 8.0% to 9.5% Outlook Company expects 2026 orga
01-30 05:16